$AIMD
Ainos, Inc.

2017 Q3 Form 10-Q Financial Statement

#000101476317000016 Filed on November 20, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q4 2016 Q3
Revenue $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $230.9K $230.0K $178.5K
YoY Change 29.36% 21.05% 57.17%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $230.9K $230.0K $178.5K
YoY Change 29.36% 21.05% 57.17%
Operating Profit -$230.9K -$230.0K -$178.5K
YoY Change 29.36% 21.05% 57.17%
Interest Expense $1.929K $0.00 $798.00
YoY Change 141.73% 33.89%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$230.0K -$230.0K -$180.0K
YoY Change 27.78% 21.05% 63.64%
Income Tax
% Of Pretax Income
Net Earnings -$232.8K -$230.0K -$179.3K
YoY Change 29.86% 21.05% 57.05%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.15 -$0.16 -$0.13
COMMON SHARES
Basic Shares Outstanding 21.39M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q3 2016 Q4 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $150.0K $130.0K $180.0K
YoY Change -16.67% 550.0% -18.18%
Cash & Equivalents $145.0K $134.1K $176.4K
Short-Term Investments
Other Short-Term Assets $70.00K $110.0K $110.0K
YoY Change -36.36% 450.0% 266.67%
Inventory $14.70K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $212.3K $262.4K $281.5K
YoY Change -24.57% 567.82% 12.59%
LONG-TERM ASSETS
Property, Plant & Equipment $31.30K $44.21K $45.87K
YoY Change -31.76% 662.57% 358.69%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $210.5K $200.3K $160.5K
YoY Change 31.18% 157.09% 78.31%
TOTAL ASSETS
Total Short-Term Assets $212.3K $262.4K $281.5K
Total Long-Term Assets $210.5K $200.3K $160.5K
Total Assets $422.8K $462.7K $442.0K
YoY Change -4.33% 294.79% 29.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $180.0K $170.0K $130.0K
YoY Change 38.46% -15.0% -40.91%
Accrued Expenses $10.00K $0.00 $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $890.0K $790.0K $790.0K
YoY Change 12.66% 107.89% 107.89%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.401M $1.273M $929.3K
YoY Change 50.81% 115.97% 52.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.401M $1.273M $929.3K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.401M $1.273M $929.3K
YoY Change 50.81% 115.97% 52.34%
SHAREHOLDERS EQUITY
Retained Earnings -$1.675M -$1.267M -$1.034M
YoY Change 62.07% 112.3%
Common Stock $230.8K $219.2K $213.9K
YoY Change 7.87% 8.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$978.6K -$809.9K -$487.3K
YoY Change
Total Liabilities & Shareholders Equity $422.8K $462.7K $442.0K
YoY Change -4.33% 294.79% 29.99%

Cashflow Statement

Concept 2017 Q3 2016 Q4 2016 Q3
OPERATING ACTIVITIES
Net Income -$232.8K -$230.0K -$179.3K
YoY Change 29.86% 21.05% 57.05%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$30.00K -$90.00K -$100.0K
YoY Change -70.0% -67.86% -183.33%
INVESTING ACTIVITIES
Capital Expenditures $10.00K $50.00K $30.00K
YoY Change -66.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$10.00K -$50.00K -$30.00K
YoY Change -66.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 120.0K 100.0K 0.000
YoY Change 25.0%
NET CHANGE
Cash From Operating Activities -30.00K -90.00K -100.0K
Cash From Investing Activities -10.00K -50.00K -30.00K
Cash From Financing Activities 120.0K 100.0K 0.000
Net Change In Cash 80.00K -40.00K -130.0K
YoY Change -161.54% -80.0% -208.33%
FREE CASH FLOW
Cash From Operating Activities -$30.00K -$90.00K -$100.0K
Capital Expenditures $10.00K $50.00K $30.00K
Free Cash Flow -$40.00K -$140.0K -$130.0K
YoY Change -69.23% -50.0% -208.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 amar Amount Of Private Placement
AmountOfPrivatePlacement
937500
amar Amount Of Private Placement
AmountOfPrivatePlacement
1875000
CY2017Q3 amar Cash Funds To Ctbc Bank Co Ltd
CashFundsToCtbcBankCoLtd
13000
CY2017Q3 amar Cash To Minimize Currency Translation Risk And To Cover Necessary Fees
CashToMinimizeCurrencyTranslationRiskAndToCoverNecessaryFees
13000
CY2017Q3 amar Common Stock Shares Outstanding And Reserved
CommonStockSharesOutstandingAndReserved
28731754
amar Conversion Of Accounts Payable Related Party To Convertible Note Payable Related Party
ConversionOfAccountsPayableRelatedPartyToConvertibleNotePayableRelatedParty
amar Conversion Of Accounts Payable Related Party To Convertible Note Payable Related Party
ConversionOfAccountsPayableRelatedPartyToConvertibleNotePayableRelatedParty
144426
amar Conversion Of Notes Payable Related Party To Convertible Note Payable Related Party
ConversionOfNotesPayableRelatedPartyToConvertibleNotePayableRelatedParty
amar Conversion Of Notes Payable Related Party To Convertible Note Payable Related Party
ConversionOfNotesPayableRelatedPartyToConvertibleNotePayableRelatedParty
384555
CY2017Q3 amar Customer Deposits Related Parties Current
CustomerDepositsRelatedPartiesCurrent
CY2016Q4 amar Customer Deposits Related Parties Current
CustomerDepositsRelatedPartiesCurrent
124833
CY2017Q3 amar Minimum Deposit Required To Open Account
MinimumDepositRequiredToOpenAccount
300000
CY2017Q3 amar Minimum Deposit Required To Open Account
MinimumDepositRequiredToOpenAccount
10000
CY2017Q3 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
886481
CY2016Q4 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
791481
amar Proceeds From Convertible Notes Payable Related Party Debt
ProceedsFromConvertibleNotesPayableRelatedPartyDebt
95000
amar Proceeds From Convertible Notes Payable Related Party Debt
ProceedsFromConvertibleNotesPayableRelatedPartyDebt
262500
CY2017Q3 amar Stock Subscription Deposit
StockSubscriptionDeposit
142107
CY2016Q4 amar Stock Subscription Deposit
StockSubscriptionDeposit
CY2017Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
175339
CY2017Q3 us-gaap Assets Current
AssetsCurrent
212331
CY2016Q4 us-gaap Assets Current
AssetsCurrent
262399
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
165502
CY2017Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
465960
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
237540
CY2017Q3 us-gaap Assets
Assets
422841
CY2016Q4 us-gaap Assets
Assets
462676
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 27pt;"> <div style=" font-family:Times New Roman, Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div></div> </td> <td> <div style=" font-family:Times New Roman, Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;">Basis of presentation.</div><div style="display: inline; font-size:10pt;font-family:Times New Roman, Times, serif;"> The accompanying financial statements, which should be read in conjunction with the audited financial statements and footnotes included in the Company's Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>as filed with the Securities and Exchange Commission on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 17, 2017, </div>have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of the results that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be expected for the full year ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.</div></div></div> </td> </tr> </table></div>
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
145029
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
134125
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21138
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
176357
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10904
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
155219
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
757904
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23078668
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21916143
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23078668
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21916143
CY2017Q3 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
4817305
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
230787
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
219161
CY2017Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
CY2016Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
us-gaap Cost Of Goods Sold
CostOfGoodsSold
58801
us-gaap Cost Of Goods Sold
CostOfGoodsSold
5100
CY2017Q3 us-gaap Cost Of Revenue
CostOfRevenue
CY2016Q3 us-gaap Cost Of Revenue
CostOfRevenue
us-gaap Cost Of Revenue
CostOfRevenue
58801
us-gaap Cost Of Revenue
CostOfRevenue
5100
CY2017Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
28584
CY2016Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
37835
CY2017Q3 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
187500
CY2016Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
187500
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2017Q3 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
179208
CY2016Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
156063
CY2017Q3 us-gaap Gross Profit
GrossProfit
CY2016Q3 us-gaap Gross Profit
GrossProfit
us-gaap Gross Profit
GrossProfit
191701
us-gaap Gross Profit
GrossProfit
-700
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2017Q3 us-gaap Interest Expense
InterestExpense
1929
CY2016Q3 us-gaap Interest Expense
InterestExpense
798
us-gaap Interest Expense
InterestExpense
7630
us-gaap Interest Expense
InterestExpense
2257
us-gaap Interest Paid
InterestPaid
CY2017Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
50625
us-gaap Operating Income Loss
OperatingIncomeLoss
-401121
us-gaap Operating Income Loss
OperatingIncomeLoss
-434876
us-gaap Interest Paid
InterestPaid
1066
CY2017Q3 us-gaap Inventory Net
InventoryNet
CY2016Q4 us-gaap Inventory Net
InventoryNet
14700
CY2017Q3 us-gaap Liabilities
Liabilities
1401445
CY2016Q4 us-gaap Liabilities
Liabilities
1272575
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
422841
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
462676
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1401445
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1272575
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
239375
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
684375
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39945
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-102168
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-188526
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-426988
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-232804
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-179268
us-gaap Net Income Loss
NetIncomeLoss
-408751
us-gaap Net Income Loss
NetIncomeLoss
-437133
CY2017Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
230875
CY2016Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
178470
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
592822
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
434176
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-230875
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-178470
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
39945
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
54483
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47685
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
38718
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
75739
CY2017Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
93750
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
144375
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
421875
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31302
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44214
CY2017Q3 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
-10018
CY2016Q4 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
-3259
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1675351
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1266600
CY2017Q3 us-gaap Revenues
Revenues
CY2016Q3 us-gaap Revenues
Revenues
us-gaap Revenues
Revenues
250502
us-gaap Revenues
Revenues
4400
CY2017Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4400
CY2017Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
CY2016Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
250502
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
230875
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
178470
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
592822
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
434176
us-gaap Stock Issued1
StockIssued1
10671
us-gaap Stock Issued1
StockIssued1
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
-978604
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-809899
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22789370
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21394810
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22500663
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20871635

Files In Submission

Name View Source Status
0001014763-17-000016-index-headers.html Edgar Link pending
0001014763-17-000016-index.html Edgar Link pending
0001014763-17-000016.txt Edgar Link pending
0001014763-17-000016-xbrl.zip Edgar Link pending
amar-20170930.xml Edgar Link completed
amar-20170930.xsd Edgar Link pending
amar-20170930_cal.xml Edgar Link unprocessable
amar-20170930_def.xml Edgar Link unprocessable
amar-20170930_lab.xml Edgar Link unprocessable
amar-20170930_pre.xml Edgar Link unprocessable
exhibit31-1a_09302017.htm Edgar Link pending
exhibit31-1b_09302017.htm Edgar Link pending
exhibit32-1_09302017.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q_09302017.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending